Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
37.09
-0.15 (-0.40%)
Mar 4, 2026, 11:48 AM EST - Market open
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.97 billion as of March 4, 2026. Its market cap has increased by 573.43% in one year.
Market Cap
5.97B
Enterprise Value
5.34B
1-Year Change
573.43%
Ranking
Category
Stock Price
$37.09
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.97B, an increase of 4,706.77%. That is a compound annual growth rate of 98.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 6.00B | 10.99% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 7.05B |
| Arcellx | 6.67B |
| Belite Bio | 6.30B |
| Rhythm Pharmaceuticals | 6.12B |
| Protagonist Therapeutics | 5.83B |
| CRISPR Therapeutics AG | 5.57B |
| Caris Life Sciences | 5.48B |
| Immunovant | 5.44B |